Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Single-Site, Phase 2 Randomized Trial

NCT05685225 is registered in ClinicalTrials.gov with Allodynic Therapeutics, Inc as lead sponsor.

NCT NCT05685225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05685225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Single-Site, Phase 2 Randomized Trial
Lead sponsor
Allodynic Therapeutics, Inc
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 2025
Completion date
December 2, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine